HOOKIPA Pharma (HOOK) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

HOOK HOOKIPA Pharma

Watchlist

2.150
-0.150-6.52%

Close Nov 22 16:00 ET

2.110
-0.040-1.86%

Post 20:01 ET

21.27MMarket Cap-585P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Hookipa Pharma Price Target Lowered to $7 From $24 at JMP Securities
Yahoo FinanceNov 22 06:51 ET
Sector Update: Health Care Stocks Climb Thursday Afternoon
MT NewswiresNov 21 13:50 ET
HOOKIPA Pharma to Cut Workforce by 80%, Shift Focus to KRAS Cancer Program
MT NewswiresNov 21 07:42 ET
HOOKIPA Pharma Price Target Cut to $7.00/Share From $24.00 by JMP Securities
Dow JonesNov 21 07:38 ET · Ratings
Hookipa Pharma Announces Workforce Reduction of 80%, Pause of Eseba-vec Program
TipRanksNov 21 06:35 ET
JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Cuts Target Price to $7
Moomoo NewsNov 21 00:32 ET · Ratings

Comments

Trytosaveabit

Nov 11 12:09

Watching!

$HOOKIPA Pharma (HOOK.US)$ Watching for news out of the presentation at SITC 2024 from Saturday!

Jaguar8

Oct 31 08:21

NEWS

$HOOKIPA Pharma (HOOK.US)$
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024
HOOKIPA Pharma (NASDAQ: HOOK) announced that updated Phase 2 data for eseba-vec (HB200) plus pembrolizumab in first-line recurrent/metastatic HPV16-positive head and neck cancer will be presented at SITC 2024. The presentation will be delivered as a late-breaking poster by Dr. Alan Ho, Chief of Head and Neck Oncology Service at Memorial Sloan Cancer Cent...

Trytosaveabit

Oct 30 06:32

Update

$HOOKIPA Pharma (HOOK.US)$ Reuters· 2 mins ago
HOOKIPA Pharma Doses First Patients With Eseba-Vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer

Trytosaveabit

Sep 24 06:48

Watching! Look at date/time!

$HOOKIPA Pharma (HOOK.US)$ HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
16 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
NEW YORK and VIENNA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK) ("HOOKIPA" or the "Company"), a clinical-stage biopharmaceutical company developing next generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced that the Company will present preclinical data related...